| $337M | ||
| $259M | ||
| $79M | ||
| $60M | ||
| $58M | ||
| $50M |
Buys | $0 | 0 | 0 |
Sells | $19,808,412 | 8 | 100 |
| POST LEONARD E | director | 0 | $0 | 7 | $208,412 | $-208,412 |
| Song Hong Fang | director | 0 | $0 | 1 | $19.6M | $-19.6M |
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.
Over the last 12 months, insiders at CG Oncology, Inc. Common stock have bought $0 and sold $19.81M worth of CG Oncology, Inc. Common stock stock.
On average, over the past 5 years, insiders at CG Oncology, Inc. Common stock have bought $7.6M and sold $19.81M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 400,000 shares for transaction amount of $7.6M was made by Decheng Capital Global Life Sciences Fund IV, L.P. (10 percent owner) on 2024‑01‑29.
| 2025-05-21 | Sale | POST LEONARD E | director | 1,000 0.0014% | $28.00 | $28,000 | -4.01% | |
| 2025-04-28 | Sale | POST LEONARD E | director | 1,000 0.0018% | $30.76 | $30,760 | -11.25% | |
| 2025-03-17 | Sale | POST LEONARD E | director | 1,000 0.0013% | $28.00 | $28,000 | -7.51% | |
| 2025-02-18 | Sale | POST LEONARD E | director | 1,000 0.0013% | $28.61 | $28,610 | -5.50% | |
| 2025-01-13 | Sale | POST LEONARD E | director | 1,000 0.0014% | $29.66 | $29,660 | -6.73% | |
| 2024-12-16 | Sale | Song Hong Fang | director | 700,000 1.0073% | $28.00 | $19.6M | -7.34% | |
| 2024-12-16 | Sale | POST LEONARD E | director | 1,000 0.0015% | $28.84 | $28,840 | -7.34% | |
| 2024-12-06 | Sale | POST LEONARD E | director | 1,000 0.0015% | $34.54 | $34,542 | -20.95% | |
| 2024-01-29 | Decheng Capital Global Life Sciences Fund IV, L.P. | 10 percent owner | 400,000 0.3234% | $19.00 | $7.6M | -4.05% |
| Song Hong Fang | director | 3003931 3.9409% | $77.68M | 0 | 1 | |
| POST LEONARD E | director | 0 0% | $0 | 0 | 7 | |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10 percent owner | 400000 0.5248% | $10.34M | 1 | 0 | <0.0001% |
$66,492,695 | 135 | 27.65% | $2.17B | |
$193,151,375 | 134 | 8.18% | $1.86B | |
$20,363,540 | 75 | 100.86% | $2.17B | |
$1,376,668 | 53 | 18.46% | $2.15B | |
$150,253,463 | 26 | -52.83% | $1.65B | |
$1,801,511 | 23 | 18.58% | $2.17B | |
$154,554,190 | 14 | 29.60% | $1.99B | |
$92,580,864 | 14 | -1.28% | $1.61B | |
$1,248,715 | 10 | 5.66% | $2.07B | |
$45,445,266 | 9 | -24.96% | $1.94B | |
$32,575,266 | 8 | 37.03% | $1.72B | |
$25,073,947 | 7 | -5.99% | $1.89B | |
$91,325,021 | 6 | 1.83% | $1.64B | |
$142,493,653 | 3 | 4.30% | $2.07B | |
$103,599,972 | 2 | -36.81% | $1.97B | |
$276,224 | 2 | -7.04% | $2.27B | |
CG Oncology, Inc. Common stock (CGON) | $7,600,000 | 1 | -4.05% | $1.97B |
$10,000,009 | 1 | 100.92% | $1.86B | |
$9,900,000 | 1 | -7.19% | $2.11B |
| Increased Positions | 88 | +61.97% | 8M | +11.83% |
| Decreased Positions | 61 | -42.96% | 4M | -5.28% |
| New Positions | 28 | New | 1M | New |
| Sold Out Positions | 26 | Sold Out | 3M | Sold Out |
| Total Postitions | 169 | +19.01% | 71M | +6.55% |
| Decheng Capital Llc | $185,097.00 | 8.38% | 6.37M | +892,859 | +16.3% | 2024-12-31 |
| Vanguard Group Inc | $170,264.00 | 7.71% | 5.86M | +779,730 | +15.35% | 2024-12-31 |
| Blackrock, Inc. | $126,514.00 | 5.73% | 4.36M | +293,930 | +7.24% | 2025-03-31 |
| Tcg Crossover Management, Llc | $106,619.00 | 4.83% | 3.67M | 0 | 0% | 2024-12-31 |
| Braidwell Lp | $95,380.00 | 4.32% | 3.28M | +112,442 | +3.55% | 2024-12-31 |
| Kynam Capital Management, Lp | $73,197.00 | 3.32% | 2.52M | +748,900 | +42.29% | 2024-12-31 |
| Fmr Llc | $70,696.00 | 3.2% | 2.43M | +2M | +1,571.36% | 2024-12-31 |
| Foresite Capital Management Vi Llc | $64,534.00 | 2.92% | 2.22M | +2M | New | 2024-12-31 |
| State Street Corp | $55,880.00 | 2.53% | 1.92M | +222,931 | +13.11% | 2024-12-31 |
| Wellington Management Group Llp | $55,499.00 | 2.51% | 1.91M | +1M | +274.44% | 2024-12-31 |